Blackrock Biotechnology ETF | IBB

Medium RiskEquity
Blackrock Biotechnology ETF
Issued by:iShares by Blackrock
Index : NASDAQ
Unit Price (NAV) :
Minimum investment: 1 unit
Blackrock Biotechnology ETF | IBB

Blackrock Biotechnology ETF | IBB


Biotechnology is the 'next big thing' in the technology sector. The Blackrock Biotechnology ETF (IBB) provides targeted exposure to equities in the biotechnology and pharmaceuticals sectors trading on the NASDAQ.


Blackrock Biotechnology ETF7.95%35.79%13.68%12.22%18.18%

Asset Class

Asset type breakdown
Stock US89.75%
Stock non-US10.16%

IBB Holdings - Top 10

NameiWeightage (%)
Amgen Inc8.14%
Gilead Sciences, Inc6.58%
Vertex Pharmaceuticals Incorporated4.87%
Illumina, Inc4.51%
Regeneron Pharmaceuticals, Inc4.40%
Moderna, Inc4.13%
Biogen Inc3.26%
Alexion Pharmaceuticals, Inc2.71%
Seagen Inc2.63%
AstraZeneca PLC2.02%

IBB Sectors/Industry Breakdown

Sectori% of market value

IBB Countries

Country% of market value
North America90.18%
Europe Developed3.79%
Asia Emerging3.22%
United Kingdom2.48%
Asia Developed0.17%
Africa/Middle East0.17%

Projected Returns

Investment ofper month
gives returns of :
at 16.01% / annum
$in 10 years
for a time period of
Returnsbased on historic SIP returns of 16.01% per annum
$+ 16.01

IBB Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Symbol IBB
Exchange XNAS
ISIN US4642875565
Cat. Benchmark MSCI ACWI NR USD
Asset class EQUITY
Category Health
Country US

IBB Portfolio Data & Volatility Analysis

Expense ratio 0.46i
Beta 0.94i
P/E ratio 12.99893i
Standard Deviation 23.09i

Fund Strategy

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

IBB Fact Sheets & Reports

About iShares by Blackrock

With more than twenty years of ETF experience, a global line-up of 800+ exchange-traded funds (ETFs) and $1.9 trillion in assets under management, iShares continually strives to unlock new opportunities for our investors. By channeling strategic thinking and expertise into a robust offering of investment funds, iShares aims to make wealth-building easier, more efficient, and more rewarding for all investors.

Blackrock Biotechnology ETF | IBB